Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of ERG Components to Discriminate Between Schizophrenia and Bipolar Disorder Type I

NCT03788811 is registered in ClinicalTrials.gov with diaMentis Inc. as lead sponsor.

NCT NCT03788811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03788811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of ERG Components to Discriminate Between Schizophrenia and Bipolar Disorder Type I
Lead sponsor
diaMentis Inc.
Phase
Observational
Overall status
Active, not recruiting
Start date
July 5, 2018
Completion date
December 31, 2026
Enrollment
300 (estimated)
Sites
19

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar i disorder, schizophrenia